GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, arexvy, influenza, and pandemic vaccines. It also provides medicine products for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. The company sells its products under the Anoro Ellipta, Nucala, Trelegy Ellipta, Ventolin, Xevudy, Keppra, Augmentin, Zejula, Blenrep, Jemperli, Ojjaara/Omjjara, Benlysta, Benlysta, Jesduvroq, Duvroq, Apretude, Cabenuva/Vocabria + Rekambys, Rukobia, Dovato, Juluca, Triumeq, Tivicay, Arexvy, Bexsero, Menveo, Synflorix, and Shingrix brand names. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
GSK just handed Moderna's biggest rival program a late-stage green light, yet traders are sending MRNA stock sharply higher. The logic behind that reaction tells you something important about where the real…
Wave Life Sciences has lost nearly 70% of its value this year, yet its RNA platform spans obesity, rare liver disease, and genetic disorders in ways that could make it irresistible to…
GSK has handed investors a remarkable run. Over the past year, the stock climbed roughly 44% from $37.79 to $54.51. If you watched from the sidelines, the question now is painfully familiar:…
William Temple Of everything C3.ai (NYSE: AI) | AI Price Prediction has promised investors over the years, tonight’s revenue number is the one that actually has to deliver. Not the deal count, not the…
Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.
Live Updates Nvidia Drives Stock Market Higher4:25pm ETStrong performance from Dow Jones Industrial Average component company Nvidia (Nasdaq: NVDA | UNH Price Prediction) helped to drive the index higher Tuesday. Nvidia stock…
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing fundamental changes about the business, making the share price cheaper allows more…
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various weight loss drugs have seen is notable, with GLP-1 agonists like Ozempic, Wegovy,…
The tech stock selloff in July surprised the market but not those investors who were paying attention. As far back as April, Goldman Sachs (NYSE:GS | GS Price Prediction) warned of the…
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher. Federal Reserve chairman Jay Powell gave his…
Private healthcare sure does seem to be working well in America, doesn’t it? With skyrocketing healthcare costs with diminishing returns, a lower life expectancy, unofficial waitlists, and absurdly high mortality rates for…
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences, Goldman Sachs, GSK, PayPal, Tesla, T-Mobile, U.S.…
